1. Anesten B, Zetterberg H, Nilsson S, Fuchs D, et al.
   Comprehensive study of cerebrospinal fluid beta2-microglobulin, a marker of central nervous system immune activation in individuals with HIV.
   AIDS 2026.
   


2. Hendrix CW, Hillier SL, Bekker LG, Badal-Faesen S, et al.
   Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing.
   AIDS 2026.
   


3. Nyein PP, Donoghoe MW, Eriobu N, Uche B, et al.
   Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial.
   AIDS 2026.
   


4. Wang Y, Yu Y, Wang P, Yang X, et al.
   Analysis of HIV Status and Related Risk Factors Among Men Who Have Sex with Men from 2019 to 2021 in Qingdao, China: A Cross-Sectional Study.
   AIDS Res Hum Retroviruses 2026;42:117-125.
   


5. Yang E, Van Brantegem P, Peloquin CA, Brooks MB, et al.
   Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.
   Clin Infect Dis 2026.
   


6. Dorward J, Masombuka X, Lewis L, Pastellides C, et al.
   Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa.
   Clin Infect Dis 2026.
   


7. Loveday M, Clarence E, Brust JCM, Waitt C, et al.
   Responding appropriately to safety signals in infants exposed to the 6-month BDLLfx/BDLCfz regimen in utero.
   Clin Infect Dis 2026.
   


8. Nellore A, Goepfert P, Tan CS, Bajema K, et al.
   IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients.
   Clin Infect Dis 2026.
   


9. Inman EM, Ramsammy CW, Kalegina A, Robbins RN, et al.
   Effects of HIV and adverse childhood experiences on neurocognition.
   J Acquir Immune Defic Syndr 2026.
   


10. Teixeira AR, Caskey M.
    What's Hot in HIV in 2025-A Basic and Translational Science Review from IDWeek 2025.
    J Infect Dis 2026.
    


11. Makori TO, Gicheru ET, Mburu MW, Sada MS, et al.
    Nasopharyngeal Microbiome Composition and its Clinical Correlates in Children Hospitalized with Severe Pneumonia in East Africa.
    J Infect Dis 2026.
    


12. Atabey T, Derking R, Newby ML, Bouhuijs JH, et al.
    Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation.
    J Virol 2026.
    


13. Orkin C, Ruane PJ, Hedgcock M, Gaultier C, et al.
    Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.
    Lancet 2026.
    


14. Cohen J.
    Community health project slashes new HIV infections.
    Science 2026;391:971.
    


15. Anketell MJ, Fung E, Liu W, Shinde M, et al.
    A unified platform for nucleoside analog synthesis.
    Science 2026.
    


16. Hakim MS, Widyaningsih SA, Ikram A, Goeijenbier M, et al.
    Fundamental concepts of convergent (parallel) evolution in human-pathogenic viruses and their implications for global health.
    Virology 2026;618:110854.
    

Display articles in

• Abstract format